Theraclion SA logo

ALTHE - Theraclion SA News Story

€1.37 0.0  2.6%

Last Trade - 2:25pm

Sector
Healthcare
Size
Micro Cap
Market Cap £18.0m
Enterprise Value £19.4m
Revenue £1.22m
Position in Universe 705th / 849

BRIEF-Theraclion: Announces Phase-2 Collaboration With University Of Virginia Cancer Center

Tue 1st June, 2021 5:03pm
June 1 (Reuters) - Theraclion SA  ALTHER.PA :
    * UVA CANCER CENTER TO EXPAND USE OF THERACLION'S HIFU SYSTEM IN CANCER
TREATMENT
RESEARCH
    * ANNOUNCES A PHASE-2 COLLABORATION WITH UNIVERSITY OF VIRGINIA CANCER
CENTER
    * EXTENDS INVESTIGATION OF COMBINING HIFU WITH IMMUNOTHERAPY FROM LATE-STAGE
TO
THAT OF EARLY-STAGE BREAST CANCER
    * IF SUCCESSFUL, SUCH A PROTOCOL COULD OPEN A NEW WAY FOR TREATMENT

Source text for Eikon:  ID:nBw5V8Nysa 
Further company coverage:  ALTHER.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
© Stockopedia 2022, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.